NYSE:CNC - Centene Stock Price, Forecast & News

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

Centene's stock split on the morning of Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were payable to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.

Centene Corp (NYSE:CNC) released its quarterly earnings data on Tuesday, February, 4th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.73. The business had revenue of $18.86 billion for the quarter, compared to the consensus estimate of $18.45 billion. Centene had a return on equity of 15.18% and a net margin of 1.77%. The firm's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period last year, the company earned $0.69 EPS. View Centene's Earnings History.

Centene is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Centene.

Centene issued an update on its FY 2020 Pre-Market earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of 4.64-4.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.80. The company issued revenue guidance of $78.6-79.4 billion, compared to the consensus revenue estimate of $84.49 billion.

17 brokerages have issued 12 month target prices for Centene's stock. Their forecasts range from $62.00 to $103.00. On average, they anticipate Centene's stock price to reach $80.41 in the next year. This suggests a possible upside of 22.8% from the stock's current price. View Analyst Price Targets for Centene.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.

News stories about CNC stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Centene earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Centene.

Some companies that are related to Centene include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Humana (HUM), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Visa (V), Micron Technology (MU), Netflix (NFLX), Boeing (BA), Home Depot (HD), Adobe (ADBE) and CVS Health (CVS).

Centene's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Capital World Investors (8.74%), FMR LLC (6.16%), State Street Corp (4.07%), Capital Research Global Investors (2.94%), Geode Capital Management LLC (1.55%) and Capital International Investors (1.35%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Jessica L Blume, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Robert K Ditmore and Tommy G Thompson. View Institutional Ownership Trends for Centene.

CNC stock was sold by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Prudential Financial Inc., Renaissance Technologies LLC, Sculptor Capital LP, AQR Capital Management LLC, Man Group plc, Alberta Investment Management Corp and Snow Capital Management LP. Company insiders that have sold Centene company stock in the last year include Jesse N Hunter, Keith H Williamson, Michael F Neidorff, Robert K Ditmore and Tommy G Thompson. View Insider Buying and Selling for Centene.

CNC stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Capital World Investors, Lyrical Asset Management LP, Capital Research Global Investors, Hotchkis & Wiley Capital Management LLC, Thrivent Financial for Lutherans, Partner Fund Management L.P. and Bridger Management LLC. View Insider Buying and Selling for Centene.

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CNC stock can currently be purchased for approximately $65.49.

Centene has a market capitalization of $27.10 billion and generates $74.64 billion in revenue each year. The company earns $1.32 billion in net income (profit) each year or $4.42 on an earnings per share basis. Centene employs 47,300 workers across the globe.View Additional Information About Centene.

The official website for Centene is http://www.centene.com/.

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]